Bulent Aydogan

Associate Professor
Biosciences Graduate Program Association
Publications
  1. Abasiyanik MF, Flood B, Lin J, Ozcan S, Rouhani SJ, Pyzer A, Trujillo J, Zhen C, Wu P, Jumic S, Wang A, Gajewski TF, Wang P, Hartley M, Ameti B, Niemiec R, Fernando M, Mishra V, Savage P, Aydogan B, Bethel C, Matushek S, Beavis KG, Agrawal N, Segal J, Tay S, Izumchenko E. Sensitive detection and quantification of SARS-CoV-2 in saliva. Sci Rep. 2021 06 14; 11(1):12425. View in: PubMed

  2. Redler G, Pearson E, Liu X, Gertsenshteyn I, Epel B, Pelizzari C, Aydogan B, Weichselbaum R, Halpern HJ, Wiersma RD. Small Animal IMRT Using 3D-Printed Compensators. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):551-565. View in: PubMed

  3. Abasiyanik MF, Flood B, Lin J, Ozcan S, Rouhani SJ, Pyzer A, Trujillo J, Zhen C, Wu P, Jumic S, Wang A, Gajewski TF, Wang P, Hartley M, Ameti B, Niemiec R, Fernando M, Aydogan B, Bethel C, Matushek S, Beavis KG, Agrawal N, Segal J, Tay S, Izumchenko E. Sensitive detection and quantification of SARS-CoV-2 in saliva. medRxiv. 2020 Dec 07. View in: PubMed

  4. Hara JH, Ahn KH, Aydogan B, Koshy M. Local Recurrence Following Total Marrow Radiation: Implications for Clinical Target Delineation. Cureus. 2020 Sep 22; 12(9):e10592. View in: PubMed

  5. Slagowski JM, Redler G, Malin MJ, Cammin J, Lobb EC, Lee BH, Sethi A, Roeske JC, Flores-Martinez E, Stevens T, Yenice KM, Green O, Mutic S, Aydogan B. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac. Med Phys. 2020 Nov; 47(11):5455-5466. View in: PubMed

  6. Waller J, Onderdonk B, Flood A, Swartz H, Shah J, Shah A, Aydogan B, Halpern H, Hasan Y. The clinical utility of imaging methods used to measure hypoxia in cervical cancer. Br J Radiol. 2020 Jul; 93(1111):20190640. View in: PubMed

  7. Sarigul N, Surucu M, Reft C, Malin M, Yegingil Z, Aydogan B. A practical method for quantifying dose in bone and lung using TLDs when using 6 and 15 MV photon beams. Phys Med Biol. 2020 03 06; 65(5):05NT01. View in: PubMed

  8. Korpics MC, Rokni M, Degnan M, Aydogan B, Liauw SL, Redler G. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments. J Appl Clin Med Phys. 2020 Mar; 21(3):184-191. View in: PubMed

  9. Redler G, Stevens T, Cammin J, Malin M, Green O, Mutic S, Pitroda S, Aydogan B. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy. Cureus. 2019 Dec 12; 11(12):e6364. View in: PubMed

  10. Ahn KH, Yenice KM, Koshy M, Slavin KV, Aydogan B. Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique. J Appl Clin Med Phys. 2019 Aug; 20(8):21-28. View in: PubMed

  11. Sarigul N, Surucu M, Aydogan B. ENERGY RESPONSE FACTOR of BeO DOSEMETER CHIPS: A MONTE CARLO SIMULATION AND GENERAL CAVITY THEORY STUDY. Radiat Prot Dosimetry. 2019 Dec 31; 185(3):303-309. View in: PubMed

  12. Epel B, Maggio MC, Barth ED, Miller RC, Pelizzari CA, Krzykawska-Serda M, Sundramoorthy SV, Aydogan B, Weichselbaum RR, Tormyshev VM, Halpern HJ. Oxygen-Guided Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):977-984. View in: PubMed

  13. Patel P, Oh AL, Koshy M, Sweiss K, Saraf SL, Quigley JG, Khan I, Mahmud N, Hacker E, Ozer H, Peace DJ, Weichselbaum RR, Aydogan B, Rondelli D. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671. View in: PubMed

  14. Ahn KH, Ozturk N, Smith B, Slavin KV, Koshy M, Aydogan B. A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 May; 17(3):171-179. View in: PubMed

  15. Wiersma RD, McCabe BP, Belcher AH, Jensen PJ, Smith B, Aydogan B. Technical Note: High temporal resolution characterization of gating response time. Med Phys. 2016 Jun; 43(6):2802-2806. View in: PubMed

  16. Ahn KH, Ozturk N, Smith B, Slavin KV, Koshy M, Aydogan B. A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 05 08; 17(3):171-179. View in: PubMed

  17. Bronova I, Smith B, Aydogan B, Weichselbaum RR, Vemuri K, Erdelyi K, Makriyannis A, Pacher P, Berdyshev EV. Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1. Am J Respir Cell Mol Biol. 2015 Oct; 53(4):555-62. View in: PubMed

  18. Woerner A, Roeske JC, Harkenrider MM, Fan J, Aydogan B, Koshy M, Laureckas R, Vali F, Campana M, Surucu M. A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals. Med Phys. 2015 Aug; 42(8):4629-35. View in: PubMed

  19. Ahn KH, Manger R, Halpern HJ, Aydogan B. Increased dose near the skin due to electromagnetic surface beacon transponder. J Appl Clin Med Phys. 2015 May 08; 16(3):4930. View in: PubMed

  20. Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell LK. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy. J Med Imaging Radiat Oncol. 2015 Jun; 59(3):386-93; quiz 394. View in: PubMed

  21. Patel P, Aydogan B, Koshy M, Mahmud D, Oh A, Saraf SL, Quigley JG, Khan I, Sweiss K, Mahmud N, Peace DJ, DeMasi V, Awan AM, Weichselbaum RR, Rondelli D. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41. View in: PubMed

  22. Koshy M, Malik R, Sher DJ, Spiotto M, Mahmood U, Aydogan B, Weichselbaum RR. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71. View in: PubMed

  23. Aqil M, Elseth KM, Vesper BJ, Deliu Z, Aydogan B, Xue J, Radosevich JA. Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways. Tumour Biol. 2014 Mar; 35(3):2403-15. View in: PubMed

  24. Vesper BJ, Onul A, Haines GK, Tarjan G, Xue J, Elseth KM, Aydogan B, Altman MB, Roeske JC, Paradise WA, De Vitto H, Radosevich JA. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol. 2013 Feb; 34(1):203-14. View in: PubMed

  25. Gorshkova I, Zhou T, Mathew B, Jacobson JR, Takekoshi D, Bhattacharya P, Smith B, Aydogan B, Weichselbaum RR, Natarajan V, Garcia JG, Berdyshev EV. Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. J Lipid Res. 2012 Aug; 53(8):1553-68. View in: PubMed

  26. Surucu M, Yeginer M, Kavak GO, Fan J, Radosevich JA, Aydogan B. Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys. 2012 Jan; 39(1):281-8. View in: PubMed

  27. Aydogan B, Yeginer M, Kavak GO, Fan J, Radosevich JA, Gwe-Ya K. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81(2):592-9. View in: PubMed

  28. Yeginer M, Roeske JC, Radosevich JA, Aydogan B. Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1256-65. View in: PubMed

  29. Tarjan G, Haines GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk YR, Khurram H, Elseth KM, Roeske JC, Aydogan B, Radosevich JA. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol. 2011 Feb; 32(1):87-98. View in: PubMed

  30. Li J, Chaudhary A, Chmura SJ, Pelizzari C, Rajh T, Wietholt C, Kurtoglu M, Aydogan B. A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol. 2010 Aug 07; 55(15):4389-97. View in: PubMed

  31. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. View in: PubMed

  32. Aydogan B, Li J, Rajh T, Chaudhary A, Chmura SJ, Pelizzari C, Wietholt C, Kurtoglu M, Redmond P. AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol. 2010 Oct; 12(5):463-7. View in: PubMed

  33. Altman MB, Stinauer MA, Javier D, Smith BD, Herman LC, Pytynia ML, Aydogan B, Pelizzari CA, Chmura SJ, Roeske JC. Validation of temporal optimization effects for a single fraction of radiation in vitro. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1240-6. View in: PubMed

  34. Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009 Nov; 93(2):298-301. View in: PubMed

  35. Altman MB, Vesper BJ, Smith BD, Stinauer MA, Pelizzari CA, Aydogan B, Reft CS, Radosevich JA, Chmura SJ, Roeske JC. Characterization of a novel phantom for three-dimensional in vitro cell experiments. Phys Med Biol. 2009 Mar 07; 54(5):N75-82. View in: PubMed

  36. Wilkie JR, Tiryaki H, Smith BD, Roeske JC, Radosevich JA, Aydogan B. Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys. 2008 Dec; 35(12):5609-18. View in: PubMed

  37. Roeske JC, Aydogan B, Bardies M, Humm JL. Small-scale dosimetry: challenges and future directions. Semin Nucl Med. 2008 Sep; 38(5):367-83. View in: PubMed

  38. Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1504-10. View in: PubMed

  39. Aydogan B, Bolch WE, Swarts SG, Turner JE, Marshall DT. Monte carlo simulations of site-specific radical attack to DNA bases. Radiat Res. 2008 Feb; 169(2):223-31. View in: PubMed

  40. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Apr 01; 70(5):1431-7. View in: PubMed

  41. Aydogan B, Mundt AJ, Roeske JC. Linac-based intensity modulated total marrow irradiation (IM-TMI). Technol Cancer Res Treat. 2006 Oct; 5(5):513-19. View in: PubMed

  42. Aydogan B, Mundt AJ, Smith BD, Mell LK, Wang S, Sutton H, Roeske JC. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):266-73. View in: PubMed

  43. Aydogan B, Marshall DT, Swarts SG, Turner JE, Boone AJ, Richards NG, Bolch WE. Site-specific OH attack to the sugar moiety of DNA: a comparison of experimental data and computational simulation. Radiat Res. 2002 Jan; 157(1):38-44. View in: PubMed